G3 Therapeutics
PrivateLast Round
Joint Venture
Jun 1, 2020
Momentum
Top 25%
of companies Caplight tracks
Company Overview
G3 Therapeutics operates in Healthcare & Life Sciences and is based in Virginia. It was founded in 2012.
G3 Therapeutics is a biotechnology company that leverages multi-omic biological big data, deep phenotyping, and artificial intelligence to discover and develop novel drug targets and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
G3 Therapeutics Comparables
Compare G3 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardiaTec | 84% | |
| Aitia | 83% | |
| Multiomic Health | 81% |
For institutional investors. Book with your work email.
G3 Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 16,147% MoM, reaching 7.6K.
- Jan 22, 2026
Monthly visitors grew 59% MoM.
For institutional investors. Book with your work email.
G3 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about G3 Therapeutics's valuation, stock price, and market status.
Is G3 Therapeutics a public or private company?
G3 Therapeutics is a private company.
What is the current stock price of G3 Therapeutics?
G3 Therapeutics is a private company, so its shares have no public market price. Caplight tracks G3 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is G3 Therapeutics worth (valuation)?
Valuation information for G3 Therapeutics is not publicly available.
Can I buy G3 Therapeutics stock?
G3 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was G3 Therapeutics's last funding round?
G3 Therapeutics's most recent funding round was Joint Venture on June 1, 2020.
Who are the main investors in G3 Therapeutics?
Investor information for G3 Therapeutics is not publicly disclosed.
Will G3 Therapeutics IPO soon?
No public IPO plans have been announced for G3 Therapeutics.
How can I track G3 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in G3 Therapeutics's shares on secondary markets.